✦ LIBER ✦

Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial

✍ Scribed by John D. Hainsworth; David R. Spigel; Jeffrey A. Sosman; Howard A. Burris III; Cindy Farley; Heather Cucullu; Kathleen Yost; Lowell L. Hart; Linda Sylvester; David M. Waterhouse; F. Anthony Greco

Book ID: 115075956
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 120 KB
Volume: 5
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2007.n.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

796 ORAL Bevacizumab, erlotinib, and ima

796 ORAL Bevacizumab, erlotinib, and imatinib in the treatment of patients (pts) with advanced renal cell carcinoma (RCC): Update of a Minnie Pearl Cancer Research Network phase I/II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

A phase I trial of imatinib in combinati

A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer

✍ M. Michael, J. Zalcberg, P. Gibbs, L. Lipton… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 251 KB

Phase II trial of echinomycin for the tr

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma

✍ M. Ernest Marshall; Michael K. Wolf; E. David Crawford; Sarah Taylor; Brent Blum 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 185 KB

A phase I/II trial of sorafenib and infl

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

✍ Larkin, J M G; Ferguson, T R; Pickering, L M; Edmonds, K; James, M G; Thomas, K; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB

Phase II study of bevacizumab and erloti

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease

✍ Thomas Yau, Hilda Wong, Pierre Chan, T. J. Yao, R. Pang, T. T. Cheung, S. T. Fan 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 156 KB

A phase I pharmacodynamic trial of seque

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

✍ Justine Yang Bruce,Jill M. Kolesar,Hans Hammers… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 396 KB